FDA Drug Application (065421) for RIFAMPIN by MYLAN LABS LTD

Back to FDA Applications sponsored by MYLAN LABS LTD

Application Number065421
Product Number001
FormINJECTABLE;INJECTION
Dosage600MG/VIAL
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AP Injectable aqueous solutions and, in certain instances, intravenous non-aqueous solutions
Reference Drug
Drug NameRIFAMPIN
Active IngredientRIFAMPIN



Back to FDA Applications sponsored by MYLAN LABS LTD

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.